Nigeria Explores Innovative Tech to Boost Local Drug Production
Nigeria's pharmaceutical sector heavily relies on imports, with 75% of pharmaceutical products being brought in from countries like India, the United Kingdom, and China. This import dependency exposes the nation to supply chain disruptions, foreign exchange volatility, and drug shortages, impacting public health and industrial development.
To address this, Nigeria is focusing on modernizing its pharmaceutical sector through innovative technology and legal and financial incentives. The National Agency for Food and Drug Administration and Control (NAFDAC) plays a key role in regulating pharmaceutical products in Nigeria, ensuring compliance with good manufacturing practices and enforcing sanctions against substandard or counterfeit drugs.
Plus234Feed summary based on reporting from Business Day. Read the original report below.
Read full article
Continue on Business Day
Get the week in one email
Top stories, NPFL results, the naira — every Friday morning. Free, one email a week.
Related Stories
NAFDAC Urges Pharma Firms to Invest in Vaccine Production for Health Security
NBRDA Partners for Local Production of HIV Drugs in Nigeria
Nigeria, EU, and France Collaborate to Boost Pharmaceutical Manufacturing in $10.2M Project
Drug Prices Soar Despite Tinubu’s Executive Order On Tariff Waivers
Tinubu’s Drug Price Executive Order Fails to Ease Cost Burden on Nigerians
NDLEA Chief Urges Action on Emerging Drug Trade Threats in Nigeria
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.
